Clinical trial
Efficacy and Safety of Rituximab Combining With Low-Dose Mycophenolate Mofetil in the Induction Therapy of Proliferative Lupus Nephritis in Children
NCT07675291 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Rituximab Combining With Low-Dose Mycophenolate Mofetil in the Induction Therapy of Proliferative Lupus Nephritis in Children
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2026
- Completion date
- December 31, 2028
- Enrollment
- 112 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.